These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'. Tan X; Johnson S Anaerobe; 2019 Dec; 60():102092. PubMed ID: 31472233 [TBL] [Abstract][Full Text] [Related]
6. Fecal microbiota transplantation for the treatment of Clostridium difficile infection. Rao K; Safdar N J Hosp Med; 2016 Jan; 11(1):56-61. PubMed ID: 26344412 [TBL] [Abstract][Full Text] [Related]
7. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients. Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585 [TBL] [Abstract][Full Text] [Related]
8. Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial. Jiang ZD; Jenq RR; Ajami NJ; Petrosino JF; Alexander AA; Ke S; Iqbal T; DuPont AW; Muldrew K; Shi Y; Peterson C; Do KA; DuPont HL PLoS One; 2018; 13(11):e0205064. PubMed ID: 30388112 [TBL] [Abstract][Full Text] [Related]
9. Fecal microbiota transplantation for recurrent Clostridioides difficile infection. Haber SL; Raney CRK; Larson TL; Lau JP Am J Health Syst Pharm; 2019 Jun; 76(13):935-942. PubMed ID: 31361890 [TBL] [Abstract][Full Text] [Related]
10. Probiotics and Fecal Microbiota Transplant for Primary and Secondary Prevention of Clostridium difficile Infection. Crow JR; Davis SL; Chaykosky DM; Smith TT; Smith JM Pharmacotherapy; 2015 Nov; 35(11):1016-25. PubMed ID: 26598094 [TBL] [Abstract][Full Text] [Related]
11. The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals. Agrawal M; Aroniadis OC; Brandt LJ; Kelly C; Freeman S; Surawicz C; Broussard E; Stollman N; Giovanelli A; Smith B; Yen E; Trivedi A; Hubble L; Kao D; Borody T; Finlayson S; Ray A; Smith R J Clin Gastroenterol; 2016; 50(5):403-7. PubMed ID: 26352106 [TBL] [Abstract][Full Text] [Related]
12. Stability and efficacy of frozen and lyophilized fecal microbiota transplant (FMT) product in a mouse model of Clostridium difficile infection (CDI). Jiang ZD; Alexander A; Ke S; Valilis EM; Hu S; Li B; DuPont HL Anaerobe; 2017 Dec; 48():110-114. PubMed ID: 28801119 [TBL] [Abstract][Full Text] [Related]
18. Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection. Kelly BJ; Tebas P Chest; 2018 Jan; 153(1):266-277. PubMed ID: 28923757 [TBL] [Abstract][Full Text] [Related]
20. Fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with solid organ transplants: an institutional experience and review of the literature. Lin SC; Alonso CD; Moss AC Transpl Infect Dis; 2018 Dec; 20(6):e12967. PubMed ID: 30011107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]